Title of article
Halothane Induced Hepatitis (CME).
Author/Authors
Fallahian، F نويسنده Gastroenterintestinal and Liver Disease Research Center, Firuzgar Hospital, Vali asr Square, Aban St. Tehran, Iran. Telephone: +98(21) 8800-3264 Fax: +98(21) 8894- 5188 ,
Issue Information
فصلنامه با شماره پیاپی 40 سال 2009
Pages
12
From page
1
To page
12
Abstract
Halothane is a halogenated inhalation anesthetic. Its three trace elements are fluoride, chloride
and bromide. Fluoride is well known by biochemists to be an inhibitor of enzymes. Fluoride
forms a strong hydrogen bond with the amide group, and thus has the potential to interfere
with fundamental life-processes involving the shape and function of both proteins and
nucleic acids. Patients with halothane hepatitis or severe hepatic damage due to other halogenated
anesthetics produce antibodies against several liver trifluoroacetylated microsomal
proteins. Other studies suggest that molecular mimicry of N6-trifluoroacetyl-L-lysin by lipoic
acid, or the impairment thereof, might play a role in the susceptibility of individuals for the
development of halothane hepatitis. The spectrum of disease differs from aminotransferase
elevation either without symptoms or with mild, self-limited symptoms to severe hepatitis or
acute liver failure. More investigation is needed to understand the mechanisms of halothane
hepatotoxicity. The aim of our report is to prevent, recognize and manage the complications
of hepatitis associated with halothane administration.
Journal title
Shiraz Electronic Medical Journal
Serial Year
2009
Journal title
Shiraz Electronic Medical Journal
Record number
1424124
Link To Document